Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5195428 | 6206034 | I | 5195428-9 | 20061217 | 20061219 | 20061230 | EXP | US-NOVOPROD-259383 | NOVOPROD | 45 | YR | F | Y | 45.351 | KG | 20061230 | CN | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5195428 | 1007999349 | PS | NOVOLOG | 1 | SUBCUTANEOUS | UNK, QD | SW50727 | 020986 | |||
| 5195428 | 1007999350 | C | TOPAMAX | 1 | ORAL | 125 MG, QD |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5195428 | 1007999349 | DIABETES MELLITUS INSULIN-DEPENDENT |
| 5195428 | 1007999350 | HEADACHE |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5195428 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5195428 | BLOOD GLUCOSE INCREASED |
| 5195428 | CHEST PAIN |
| 5195428 | DEVICE FAILURE |
| 5195428 | DYSPNOEA |
| 5195428 | VOMITING |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5195428 | 1007999349 | 20040101 | |||
| 5195428 | 1007999350 | 20040101 |